Lars Barkler

Part of Sensata Technologies Holding Plc, Impress Sensors & Systems Ltd. is a British company that manufactures and distributes instrumentation. The company is based in Wimborne, UK. Impress Sensors & Systems was founded in 2002.

Acarix A/S engages in development, production and advertisement of a new cardiovascular diagnostic methods and equipment. It develops engages in the non-invasive and non-radiation acoustic detection of coronary artery disease. The firm designs CADScor, a sensor that records, processes, and displays heart signal. The company was founded in 2009 and is headquartered in Kongens Lyngby, Denmark.

Forendo Pharma Oy provides novel pharmaceutical treatments for endometriosis and low testosterone levels. Its product fispemifene is the first selective estrogen receptor modulator designed only for men, which helps for the treatment of symptoms of low testosterone, in phase II clinical studies in men with secondary hypogonadism; fispemifene has normalized the low testosterone levels. Its 17HSD1-inhibitor focuses on endometriosis, is a potent and selective lead compounds demonstrated in vivo proof of efficacy in disease model of endometriosis. The company was founded by Risto Arvo Sakari Lammintausta in 2013 and is headquartered in Turku, Finland.

Part of Sunstone Capital A/S, Sunstone Life Science Ventures A/S is a Danish company that provides investment services. The company is based in Copenhagen, Denmark.

ReWind Therapeutics NV is a biotech company based in Leuven, Belgium that develops first-in-class remyelinating therapies for myelin-related diseases. The Belgian company's aim is to bring these therapies into fast-track clinical development. Myelin-related diseases, such as multiple sclerosis, are those where the myelin sheath surrounding nerves is damaged, leading to deficient nerve transmission that may affect multiple functions, including sensation, cognition, and movement, among others. ReWind Therapeutics develops first-in-class therapeutics designed to re-initiate the process of remyelination in patients suffering from major debilitating diseases such as multiple sclerosis, optic neuritis, or nerve injuries. The company's team has extensive R&D expertise and has built a strong patent estate for developing novel remyelination therapeutics. The company was founded in 2017 by Ku Leuven's Centre for Drug Design and Discovery (CD3) and Axxam S.p.A. The CEO of the company since 2021 is Anja Harmeier.

Eltel Group Oy builds and connects Infranet solutions for power transmission and distribution networks. The firm specializes in combining these technologies into an emerging intelligent infrastructure called Infranet, dedicated to boosting the way society works. Its specialized business units provide leading solutions for power transmission and distribution networks, fixed and mobile telecommunications, homeland security and aviation, and rail and road infrastructures. The company was founded in September 14, 2004 and is headquartered in Espoo, Finland.

Founded in 2014, ST Schrader Holding Company UK Ltd. is a subsidiary of Sensata Technologies Holding Plc. The company is based in Swindon, UK. The British company manufactures, develops, and sells sensors and controls.

Part of Sensata Technologies Holding Plc, August UK HoldCo Ltd. is a company that manufactures, develops, and sells sensors and controls. The company is based in Royal Wootton Bassett, UK and was founded in 2012.

Quanergy Perception Technologies, Inc. develops software for capturing and processing 3D mapping data. It operates as a technology company that engages in developing smart sensing solutions for real-time 3D mapping and object detection, tracking and classification. The firm manufactures 3D time-of-flight LiDAR sensors and LiDAR-based sensing systems. Its markets include passenger vehicles, corporate, commercial, municipal fleets and digital mapping fleets, logistics, robotics, unmanned aerial vehicles (UAVs), wind turbine preservation, inspection, security, and disaster relief. The company was founded by Louay Eldada, Tianyue Yu and Angus Pacala in November 2012 and is headquartered in Sunnyvale, CA.

Founded in 2018, Sensata Technologies Intermediate UK Ltd. is a holding company that oversees subsidiaries involved in the development, manufacturing, and sale of sensors and control products. The company is based in Swindon, UK.

Combitech Systems Ab develops integrated hardware and software solutions for embedded real-time systems. The private company is based in Stockholm, Sweden and has subsidiaries in Sweden.

Part of Masco Corp., Masco Europe SARL is a company based in Munsbach, Luxembourg.

LEGO System A/S manufactures games and toys. The company was founded in July 01, 1973 and is headquartered in Billund, Denmark.

Dansk A/S provides freight trucking and transportation services. Dantra which is domiciled in Hjøllund in Jutland, now have a truck fleet of more than 100 modern and specialized tankers, daily carrying liquid products throughout Scandinavia and Europe. Transportation includes food / food, temperature controlled transport, chemicals, engineering products, oil / gasoline, heavy fuel(black oil) bio fuel, Jet A1 aviation fuel, marine and skibsbunkringer and large truck traffic. The company was founded in 1920 and is headquartered in Hjøllund, Denmark

Noj Fonden operates as a charitable trust. The private company is based in Langelinie Allé, Denmark. and has subsidiaries in Denmark.

Sunstone Lsv & Co. The private company is based in Copenhagen, Denmark. Invest Ill Holding Aps functions as an investment holding Danish company.

Life Science Ventures provides financial advice.

Sunstone Capital A/S (Sunstone) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2007 by Peter Benson, Sten Verland, and Søren Lemonius, and invests on behalf of a group of institutional investors.

Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark.